- $22.12bn
- $56.04bn
- $11.95bn
- 45
- 76
- 87
- 79
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Interest Income | |||||
Interest Expense | |||||
Net Interest Income | 2,565 | 2,204 | 1,962 | 2,542 | 2,465 |
Loan Loss Provision | |||||
Net Interest Income After Loan Loss Provision | 2,555 | 2,116 | 1,995 | 2,522 | 2,419 |
Non Interest Income | |||||
Non Interest Expense | |||||
Net Income Before Taxes | 2,712 | 2,899 | 3,171 | 3,327 | 2,316 |
Provision for Income Taxes | |||||
Net Income After Taxes | 2,242 | 2,420 | 2,693 | 2,774 | 1,944 |
Net Income Before Extraordinary Items | |||||
Net Income | 2,242 | 2,420 | 2,693 | 2,774 | 1,944 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 2,009 | 2,257 | 2,572 | 2,660 | 1,821 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 6.07 | 7.13 | 7.85 | 7.41 | 6.69 |
Dividends per Share |